{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T05:36:17Z","timestamp":1762061777715,"version":"build-2065373602"},"reference-count":96,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bayer Vietnam"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Polypoidal choroidal vasculopathy (PCV) is a common choroidal disease in the Asian population including Vietnam and is characterized by subretinal red-orange nodules, pigmented epithelium detachment, and massive subretinal hemorrhage. The recent focus on PCV in Vietnam can be attributed to advancements in PCV diagnosis and treatment. However, there is a scarcity of published literature and clinical data on PCV in the Vietnamese population, highlighting a key knowledge gap in this region. In order to address this gap, we gathered the opinions of experienced clinicians and retinal experts in Vietnam and reviewed available medical literature with the aim of: (i) providing an overview of PCV in the Vietnamese population\u2014in terms of epidemiology, clinical characteristics, and management; (ii) tailoring international\/national guidelines for the diagnosis and management of PCV, in line with available resources and medical equipment in Vietnam; and (iii) identifying gaps in clinical data in order to guide future PCV research in Vietnam and other countries with similar clinical conditions. The present review will enable healthcare providers and researchers to gain insight into current clinical practices and the limitations of PCV management in Vietnam and provide optimal and effective solutions.<\/jats:p>","DOI":"10.3390\/jcm11164678","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T09:42:56Z","timestamp":1660124576000},"page":"4678","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current Trends in Clinical Characteristics, Diagnosis, and Treatment of Polypoidal Choroidal Vasculopathy: A Perspective from Vietnam"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-6039","authenticated-orcid":false,"given":"Dang","family":"Dat","sequence":"first","affiliation":[{"name":"Outpatient Department, Vietnam National Eye Hospital, 85 Ba Trieu, Nguyen Du Ward, Hai Ba Trung District, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen","family":"Hien","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hanoi Medical University, 1 Ton That Tung Street, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen","family":"Quan","sequence":"additional","affiliation":[{"name":"Phuong Dong International Eye Center, 71 Ngo Thoi Nhiem Street, District 3, Ho Chi Minh City 700000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-1829","authenticated-orcid":false,"given":"Mai","family":"Tung","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hanoi Medical University, 1 Ton That Tung Street, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang","family":"Tam","sequence":"additional","affiliation":[{"name":"Ophthalmology and Refractive Surgery Department, FV Hospital, 6 Nguyen Luong Bang Street, Phu My Hung, District 7, Ho Chi Minh City 700000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bui","family":"Hung","sequence":"additional","affiliation":[{"name":"Vitreoretial Department, Vietnam National Eye Hospital, 85 Ba Trieu, Nguyen Du Ward, Hai Ba Trung District, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis","volume":"2","author":"Wang","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.APO.0000656976.47696.7d","article-title":"Genetic Association of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy","volume":"9","author":"Chen","year":"2020","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4103\/ijo.IJO_1136_17","article-title":"Polypoidal choroidal vasculopathy: Pearls in diagnosis and management","volume":"66","author":"Anantharaman","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.oret.2018.08.008","article-title":"Clinicopathologic Correlation of Aneurysmal Type 1 Neovascularization in Age-Related Macular Degeneration","volume":"3","author":"Li","year":"2019","journal-title":"Ophthalmol. Retin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00006982-199010010-00002","article-title":"The posterior uveal bleeding syndrome","volume":"10","author":"Kleiner","year":"1990","journal-title":"Retina"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12886-020-01443-8","article-title":"Clinical implications of pachyvessels in polypoidal choroidal vasculopathy","volume":"20","author":"Ijuin","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ajoc.2017.10.012","article-title":"Pathologic study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo-vascularization","volume":"11","author":"Tso","year":"2018","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2147\/OPTH.S33879","article-title":"Choroidal excavation with polypoidal choroidal vasculopathy: A case report","volume":"6","author":"Kobayashi","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"ref_12","unstructured":"Vietnamese Ministry of Health (2022, May 03). Diagnosis and Treatment of Some Common Retinal Retinopathy Diseases. Available online: https:\/\/thuvienphapluat.vn\/van-ban\/The-thao-Y-te\/Quyet-dinh-4928-QD-BYT-2019-tai-lieu-Huong-dan-chan-doan-va-dieu-tri-benh-dich-kinh-vong-mac-431568.aspx."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.survophthal.2003.10.007","article-title":"Polypoidal choroidal vasculopathy","volume":"49","author":"Ciardella","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/bjophthalmol-2020-317537","article-title":"T and genetic variations between Asian and Caucasian polypoidal choroidal vasculopathy","volume":"105","author":"Teo","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40942-017-0060-4","article-title":"Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom","volume":"3","author":"Alasil","year":"2017","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","article-title":"Polypoidal Choroidal Vasculopathy: Incidence, Demographic Features, and Clinical Characteristics","volume":"121","author":"Sho","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1167\/iovs.10-5554","article-title":"CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation","volume":"51","author":"Hayashi","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3928\/15428877-20091030-07","article-title":"Polypoidal choroidal vasculopathy in Taiwanese patients","volume":"40","author":"Chang","year":"2009","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00417-003-0667-z","article-title":"Polypoidal choroidal vasculopathy in elderly Chinese patients","volume":"242","author":"Wen","year":"2004","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bjo.86.8.892","article-title":"Polypoidal choroidal vasculopathy in Chinese patients","volume":"86","author":"Kwok","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_22","unstructured":"Dang, D.T., Quoc, T.M., Chi, T.H., Nhu, Q.N., ThiNgoc, H.N.D., and Viet, H.B. (2022). Survey on polypoidal choroidal vasculopathy practice pattern in Vietnam. Correspondence: Outpatient Department, Vietnam National Eye Hospital, 85 Ba Trieu, Nguyen Du Ward, Hai Ba Trung District, Hanoi, Vietnam, manuscript in preparation; to be submitted."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kumar, A., Kumawat, D., Sundar, M.D., Gagrani, M., Gupta, B., Roop, P., Hasan, N., Sharma, A., and Chawla, R. (2019). Polypoidal choroidal vasculopathy: A comprehensive clinical update. Ther. Adv. Ophthalmol., 11.","DOI":"10.1177\/2515841419831152"},{"key":"ref_24","unstructured":"Hien, N. (2021). Research on Clinical Characteristics and Treatment Outcome in Polypoidal Choroidal Vasculopathy. [Ph.D. Thesis, Hanoi Medical University]."},{"key":"ref_25","unstructured":"Dat, D. (2017). The Study on Using Bevacizumab Intravitreal Injection for the Treatment of Neovascular Age-Related Macular Degeneration. [Ph.D. Thesis, Hanoi Medical University]."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000355488","article-title":"Polypoidal choroidal vasculopathy: Clinical features and genetic predisposition","volume":"231","author":"Honda","year":"2014","journal-title":"Ophthalmologica"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Woo, S.J., Ahn, J., Morrison, M.A., Ahn, S.Y., Lee, J., Kim, K.W., DeAngelis, M.M., and Park, K.H. (2015). Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132771"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ophtha.2010.09.026","article-title":"Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons","volume":"118","author":"Cackett","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0039-6257(98)00002-2","article-title":"The association between cigarette smoking and ocular diseases","volume":"42","author":"Solberg","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.ophtha.2006.12.021","article-title":"Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration","volume":"114","author":"Kikuchi","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcjo.2016.02.012","article-title":"Hypertension as a risk factor for recurrent subretinal hemorrhage in polypoidal choroidal vasculopathy","volume":"51","author":"Chung","year":"2016","journal-title":"Can. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.ophtha.2009.06.013","article-title":"Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients","volume":"116","author":"Ueta","year":"2009","journal-title":"Ophthalmology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1010539518824810","article-title":"Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis","volume":"31","author":"Meiqari","year":"2019","journal-title":"Asia Pac. J. Public Health"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Viet Nguyen, C., Le, T.T., and Nguyen, N.H. (2021). The impact of cigarette prices on smoking participation and tobacco expenditure in Vietnam. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260415"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00006982-200104000-00004","article-title":"Polypoidal choroidal vasculopathy in Italy","volume":"21","author":"Mariotti","year":"2001","journal-title":"Retina"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s004170000180","article-title":"Polypoidal choroidal vasculopathy in Caucasians","volume":"238","author":"Lafaut","year":"2000","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/tjo.tjo_35_18","article-title":"Polypoidal choroidal vasculopathy: An update on current management and review of literature","volume":"9","author":"Palkar","year":"2019","journal-title":"Taiwan J. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5301\/ejo.5000532","article-title":"Pilot study of inactive polypoidal lesions in polypoidal choroidal vasculopathy","volume":"25","author":"Zeng","year":"2015","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/IAE.0000000000000255","article-title":"Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: The group experience with digital fundus photography and confocal scanning laser ophthalmoscopy","volume":"34","author":"Cheung","year":"2014","journal-title":"Retina"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2018.05.005","article-title":"Color Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography in Diagnosing Polypoidal Choroidal Vasculopathy","volume":"192","author":"Chaikitmongkol","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/bjophthalmol-2020-317011","article-title":"Fractal analysis of polypoidal choroidal neovascularisation in age-related macular degeneration","volume":"105","author":"Serra","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaophthalmol.2019.0565","article-title":"Sensitivity and Specificity of Potential Diagnostic Features Detected Using Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography for Polypoidal Choroidal Vasculopathy","volume":"137","author":"Chaikitmongkol","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"ref_45","first-page":"165","article-title":"New Concepts in Polypoidal Choroidal Vasculopathy Imaging: A Focus on Optical Coherence Tomography and Optical Coherence Tomography Angiography","volume":"8","author":"Teo","year":"2019","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ajo.2014.08.025","article-title":"Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy","volume":"158","author":"Keane","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.neo.7900071","article-title":"Optical coherence tomography: An emerging technology for biomedical imaging and optical biopsy","volume":"2","author":"Fujimoto","year":"2000","journal-title":"Neoplasia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40942-022-00365-5","article-title":"Optical coherence tomography in diagnosing polypoidal choroidal vasculopathy. Looking into the future: A systematic review and meta-analysis","volume":"8","author":"Permadi","year":"2022","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IAE.0000000000000794","article-title":"Distinguishing polypodal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/0301-4738.159860","article-title":"En-face optical coherence tomography in the diagnosis and management of age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"63","author":"Lau","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ophtha.2010.09.012","article-title":"Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration","volume":"118","author":"Chung","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1167\/iovs.12-9619","article-title":"Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"53","author":"Jirarattanasopa","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"17848","DOI":"10.1038\/s41598-021-97340-1","article-title":"Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography","volume":"11","author":"Ma","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_54","first-page":"OCT324-30","article-title":"Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Optical Coherence Tomography Angiography","volume":"509","year":"2022","journal-title":"Vietnam Med. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6837601","DOI":"10.1155\/2019\/6837601","article-title":"Detection Rate and Diagnostic Value of Optical Coherence Tomography Angiography in the Diagnosis of Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1637377","DOI":"10.1155\/2021\/1637377","article-title":"Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography","volume":"2021","author":"Azar","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ceo.12580","article-title":"Comparison of swept source optical coherence tomography and spectral domain optical coherence tomography in polypoidal choroidal vasculopathy","volume":"43","author":"Ting","year":"2015","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/17434440.2021.1963230","article-title":"En face swept-source optical coherence tomography angiography choroidal vasculography (CVG) a tool to discriminate choroidal abnormalities in polypoidal choroidal vasculopathy","volume":"18","author":"Arias","year":"2021","journal-title":"Expert Rev. Med. Devices"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.eye.6702955","article-title":"Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy","volume":"23","author":"Lee","year":"2009","journal-title":"Eye"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0974-620X.192263","article-title":"Combined argon laser photocoagulation and antivascular endothelial growth factor for management of macular polypoidal choroidal vasculopathy","volume":"9","author":"Sen","year":"2016","journal-title":"Oman J. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","article-title":"Panretinal Photocoagulation: A Review of Complications","volume":"33","author":"Reddy","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.18240\/ijo.2021.09.16","article-title":"Long-term outcomes of focal laser photocoagulation for the treatment of polypoidal choroidal vasculopathy","volume":"14","author":"Choe","year":"2021","journal-title":"Int. J. Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajo.2013.04.001","article-title":"Photodynamic therapy versus combination therapy in polypoidal choroidal vasculopathy: Changes of aqueous vascular endothelial growth factor","volume":"156","author":"Lee","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","article-title":"Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization","volume":"141","author":"Tong","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41433-021-01688-7","article-title":"Evolving treatment paradigms for PCV","volume":"36","author":"Fenner","year":"2022","journal-title":"Eye"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/s41598-021-82316-y","article-title":"Systematic review with network meta-analysis of antivascular endothelial growth factor use in managing polypoidal choroidal vasculopathy","volume":"11","author":"Chi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10384-010-0813-1","article-title":"Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab","volume":"54","author":"Tsujikawa","year":"2010","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjo.2008.150029","article-title":"Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results","volume":"94","author":"Kokame","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ajo.2013.05.024","article-title":"Comparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study results","volume":"156","author":"Oishi","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e11188","DOI":"10.1097\/MD.0000000000011188","article-title":"Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity","volume":"97","author":"Mori","year":"2018","journal-title":"Medicine"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wu, W.C., Chen, J.T., Tsai, C.Y., Wu, C.L., Cheng, C.K., Shen, Y.D., Tsai, A., and Wu, P.C. (2020). A 12-month, prospective, observational study of ranibizumab in treatment-na\u00efve Taiwanese patients with neovascular age-related macular degeneration: The RACER study. BMC Ophthalmol., 20.","DOI":"10.1186\/s12886-020-01715-3"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: Efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and Safety of Ranibizumab with or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"ref_74","first-page":"1130","article-title":"Practicability confirmation by meta-analysis of intravitreal ranibizumab compared to photodynamic therapy to treat polypoidal choroidal vasculopathy","volume":"21","author":"Liu","year":"2015","journal-title":"Mol. Vis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ajo.2014.05.025","article-title":"Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration","volume":"158","author":"Fauser","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ajo.2013.06.020","article-title":"Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration","volume":"156","author":"Muether","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2147\/DDDT.S40215","article-title":"Aflibercept in wet AMD: Specific role and optimal use","volume":"7","author":"Semeraro","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_78","unstructured":"Shah, V.A., Tripathy, K., Bhagat, N., Lim, J.I., and Karth, P.A. (2022, May 16). Aflibercept. Available online: https:\/\/eyewiki.aao.org\/Aflibercept#Ophthalmology."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.2007.134874","article-title":"Predicted biological activity of intravitreal VEGF Trap","volume":"92","author":"Stewart","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000477448","article-title":"One-Year Outcomes following Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in Japanese Patients: The APOLLO Study","volume":"238","author":"Oshima","year":"2017","journal-title":"Ophthalmologica"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00417-016-3489-5","article-title":"Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study","volume":"255","author":"Lee","year":"2017","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2019.02.027","article-title":"Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study","volume":"204","author":"Wong","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00417-014-2838-5","article-title":"Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"253","author":"Kawashima","year":"2015","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/IAE.0000000000001047","article-title":"Angiographic findings of Ranibizumba-resistant polypoidal choroidal vasculopathy after switching to a treat-and-extend regimen with intravitreal aflibercept","volume":"36","author":"Azuma","year":"2016","journal-title":"Retina"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/s41598-017-16476-1","article-title":"Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy","volume":"7","author":"Kikushima","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2016.02.019","article-title":"Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal Vasculopathy","volume":"165","author":"Cho","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"20115","DOI":"10.1038\/s41598-021-99634-w","article-title":"Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy","volume":"11","author":"Ma","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/APO.0000000000000445","article-title":"Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations from the Asia-Pacific Vitreo-retina Society","volume":"10","author":"Chaikitmongkol","year":"2021","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ophtha.2020.06.028","article-title":"HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration","volume":"128","author":"Dugel","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bjophthalmol-2021-319090","article-title":"Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK","volume":"106","author":"Ogura","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ophtha.2020.11.011","article-title":"Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER","volume":"128","author":"Srivastava","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ophtha.2020.04.017","article-title":"Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab","volume":"127","author":"Baumal","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Fukuda, Y., Sakurada, Y., Matsubara, M., Hasebe, Y., Sugiyama, A., Kikushima, W., and Kashiwagi, K. (2021). Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy. Biomedicines, 9.","DOI":"10.3390\/biomedicines9091164"},{"key":"ref_96","unstructured":"(2022, May 16). Guidance for Treating Physicians. Available online: https:\/\/www.brolucizumab.info\/guidance-treating-physicians."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/16\/4678\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:06:49Z","timestamp":1760141209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/16\/4678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":96,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["jcm11164678"],"URL":"https:\/\/doi.org\/10.3390\/jcm11164678","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2022,8,10]]}}}